Key result
Cost-effectiveness analysis is essential in neurosurgery to reconcile the competing goals of advancing medical therapies and limiting healthcare costs.
Highlights the importance of cost-effectiveness analysis in neurosurgery to reconcile advancing therapies with healthcare cost limitations.
Rapid advancement of medical and surgical therapies, coupled with the recent preoccupation with limiting healthcare costs, makes a collision of the 2 objectives imminent. This article explains the value of cost-effectiveness analysis (CEA) in reconciling the 2 competing goals, and provides a brief introduction to evidence-based CEA techniques. The historical role of CEA in determining whether new neurosurgical strategies provide value for cost is summarized briefly, as are the limitations of the technique. Finally, the unique ability of the neurosurgical community to provide input to the CEA process is emphasized, as are the potential risks of leaving these important decisions in the hands of others.
No takes yet. Share an insight, caveat, or question.
Sherman C. Stein (2017) conducted an editorial in Neurosurgery. Cost-effectiveness analysis (CEA) was evaluated. Cost-effectiveness analysis is essential in neurosurgery to reconcile the competing goals of advancing medical therapies and limiting healthcare costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: